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 Abstract 
One of the important keys to characterize the biological function of a protein is 
the study of post-translational modification (PTM).  Formation of disulfide bond linkages 
between cysteine residues within a protein is a common PTM which not only contributes 
to folding and stabilizing the protein structure, but also to accomplishing its native 
function.  Therefore, the study and discovery of structural-functional relationships of 
expressed proteins using an isolated proteomics approach has been one of the biggest 
advances within the field of structural biology in recent years.  In this study, rapid 
disulfide bond mapping of freshly obtained equine serum albumin (ESA) was performed 
using matrix assisted laser desorption/ionization time of flight mass spectrometry 
(MALDI-TOF MS).  Highly sensitive MALDI-TOF MS is commonly used for the 
investigation of disulfide bond linkages in the proteomics field.  However, it has also 
been known that the presence of disulfide bond linkages absorbs the energy which is 
created by the cysteine-cysteine kinetic vibration, resulting in a decrease of the 
instrumental sensitivity.  To overcome this problem, the disulfide bond mapping method 
was optimized by applying a combination of chemical labeling, proteolytic enzymes, and 
matrices.  With the optimized method, we were also able to achieve high protein 
sequence coverage.  Obtaining higher sequence coverage of a protein provides more 
information about a protein which helps to identify the protein by peptide mass 
fingerprint (PMF) technique.  These analyses eventually contribute to the estimation of 
the possible PTM sites.   
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 CHAPTER 1 - Introduction 
Post-Translational Modification 
To better understand structural-function relationships in proteins, studying their 
post-translational modifications (PTM) is essential.  A variety of PTMs have been 
discovered and studied, including attachment of phosphates, lipids and sugars.  Due to the 
presence of these additional appended groups, proteins can be altered with respect to 
stability or activity.  As of 2006, at least 350 different types of PTMs had been reported.1  
Due to the extensive progress in PTM research in recent years, the number of distinct 
PTMs discovered has been increasing.  Even though many PTMs have been discovered, 
characterization of many of them has proven to be a difficult task.  Identification and 
characterization of a PTM can be difficult because such identification is labor-intensive, 
the database for the genome can be incomplete and there are no standardized 
methodologies.1  Various clinical research groups produced protein-based 
biopharmaceuticals involving a broad range of PTMs, with many of these having at least 
one, or more likely a combination of two or more PTMs.   
Glycosylation is one of the most common PTMs along with carboxylation and 
hydroxylation.  It has been reported that nearly 50 % of human proteins are glycosylated. 
2-3  Glycosylation includes the attachment of mono, oligo, and extended polysaccharide 
chains.  Glycosylation is reported to help proteins fold correctly and therefore to be 
stabilized better with often enhanced solubility.2  Besides glycosylation, one of the other 
significant PTMs is formation of disulfide bonds.   
Formation of Disulfide Bonds 
The formation of disulfide bond linkages contributes to the stabilization of the 
protein’s tertiary structure.  This makes proteins which have larger numbers of amino 
acid residues between two bond forming cysteines more stable.  The location of cysteines 
within a protein greatly affects the conformation of natively folded protein.  Besides 
stabilizing the structure of protein, disulfide bonds also influence activation or regulation 
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of potential function of protein by forming correct or incorrect bondings.3-5  In order to 
form a disulfide bond, two cysteine residues in a protein must be co-oxidized.  Cysteine 
is the only amino acid among 20 major encoded amino acids that contains a reactive 
sulfur atom.  This sulfhydryl group can function in many ways.  It generally exists by 
forming native disulfide bond with other present cysteines in the lumen of the 
endoplasmic reticulum to maintain its native bioactivity or stay as free (reduced) cysteine 
which also functions as a regulator or a substance carrier in many given biological 
systems.4-8  In a review article by Mamathambika,9 four major factors are emphasized; 
concentration of thiolate anion (-Sˉ), accessibility, proximity, and reactivity of the 
thiolate anion or bond linkage can all affect formation of disulfide bonds.  Also, when the 
native disulfide bond and a sulfhydryl group of free cysteine come closer, disulfide bond 
exchange can occur between already formed disulfide bond and a free cysteine as it is 
shown below. 
R1-SH + R2S-SR2  ⇋  R1S-SR2 + R2-SH 10 
The equilibrium constant for the disulfide bond exchange can be varied by the 
stability of each bond.  Because sulfhydryl groups usually stay in the reduced form within 
a cell, new disulfide bond formation is more likely to occur extracellularly where the pH 
is higher by breaking original bond with possible presence of reducing agent such as 
glutathione.  The pKa of cysteine sulfhydryl group normally is 8.37, therefore reoxidation 
to form new bond most likely happens at higher pH values.9 
R-SH  ⇋  R- S- …H+ ⇋  R-S- 
Under certain condition, pKa value of cysteine can be shifted depending on the 
surrounding environment within a protein.  For example, Keap1 protein, the repressor of 
Nrf2 which acts in the role of transcriptional activation of phase 2 genes, could have a 
lower pKa values than usual.  Nrf2 is normally bound to the cytoplasm through Keap1 
which is anchored to the cytoskeleton.  These two form a complex and regulate phase 2 
gene transcription.  Murine Keap1 is 624 amino acid long protein and contains 25 
cysteines in which 4 cysteines are identified to be most reactive.  When these 4 cysteines 
which are located on the binding domain are modified, Nrf2/Keap1 complex is disrupted.  
This disruption causes Nrf2 to be dissociated from Keap1 and moved to nucleus where it 
accelerates the transcription.  Because these 4 cysteines are located adjacent to the basic 
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residues which have higher side chain pKa values, pKa of cysteines would be lower than 
usual.  It is not uncommon to see the case where cysteine pKa values are shifted due to 
the change in its surrounding conditions.11-12   
Formation of disulfide bonds is certainly necessary for plants as well.  Disulfide 
bond formation can reversibly be regulated by signaling element which controls gene 
expression level of chloroplast in many plant’s metabolic pathways.13   It is also known 
that some protein folding mechanisms first require disulfide isomerase and a formation of 
non-native disulfide bonding in order to form correct disulfide bonds later.9, 14   If a 
protein was not folded correctly, the protein can lose its original function and become 
aggregated or degraded by proteases.  Proteins containing multiple or odd numbers of 
cysteines are still capable of forming correct disulfide bonds and this fact indicates high 
specificity of disulfide bond formation.  The bovine cathepsin C (CC), a lysosomal 
cysteine protease, is a tetramer, made of four identical monomers, and contains 13 
cysteines per each monomer.  Out of 13 cysteines, 10 cysteines were confirmed to be 
participating in the formation of disulfide bonds while the remaining 3 cysteines were 
identified to be free.  Among those three cysteines, one is classified to be an inaccessible 
buried residue while another cysteine is a catalytic residue located in the active site.  One 
last free cysteine becomes exposed during the activation process and can cause 
dissociation of the tetramer into dimers which indicates that this free cysteine 
significantly contributes to the maintenance of the original structure.15  Identifying 
existing disulfide bonds in the protein leads to understanding of functional mechanism of  
the protein.16  Disulfide bond formation is necessary for a protein to perform its function. 
However, determination of the disulfide bond can be challenging due to the presence of 
unstable intermediates and other technical concerns which discussed later.9, 16-17   
Disulfide Bond Assignment 
Determination of the structure of a protein in its native state gives us many clues 
to understand the functional properties of the protein.  It is often difficult to perform a full 
structural analysis of a protein at its native state due to larger molecular weights and 
numerous PTMs.18  NMR (nuclear magnetic resonance spectroscopy), X-ray 
Crystallography, and Edman Degradation have essentially been used to study structural 
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aspects of protein.  These methods are used to analyze and identify disulfide bonds.  
However, these methods can be limited by several factors.  Sample concentration is one 
aspect that limits an analytical method.  It will also depend on protein’s purity and 
sensitivity of the instrument.  NMR usually requires highly purified sample, greater than 
90 % purity, in a milligram scale.  Likewise, x-ray crystallography will most likely 
require equal or higher amounts of purified samples for crystallizations.  Purifying 
samples can be challenging if the sample is not abundant or is difficult to extract.  
Furthermore, x-ray crystallography uses proximity of neighboring cysteines to estimate 
disulfide bond linkages rather than actually measuring real disulfide bonds.  Also, there is 
always extra time needed for the data processing steps.  After raw experimental data are 
collected, both NMR and x-ray crystallography require data conversion or processing by 
computer to actually obtain analytically comparable data.  Edman Degradation can be 
useful if sample is a peptide, generally less than 5000 in molecular weight.  The reaction 
efficiency of each degradation step is relatively high which leads to prevention of sample 
loss.  However, this method still requires a large quantity of chemical reagents and time 
throughout the experiment.8,19  Additionally, it can only analyze one pure peptide at a 
time and sample must have a free N-terminal to initiate degradation reaction.     
Mass Spectrometry Analysis 
Mass Spectrometry (MS) has been contributing to the wide range of research 
fields especially in the proteomics research in the past few decades.  Recently, it has 
often been used to obtain a variety of information such as sequencing of protein and 
investigation of protein’s original structural characteristics including the assignment of 
disulfide bonding.3-4,8,14,16,20-26  MS is highly sensitive, regularly using only pico or femto 
mol amounts which is much less than that required by the other analytical instruments 
discussed above.  Because amount of sample required for MS analysis is relatively small, 
it can be processed from either a solution or a gel.  MS can analyze sample at the native 
state since it does not require any crystallization or treatment with organic or inorganic 
solutions.   
Electrospray ionization mass spectrometry (ESI-MS) and matrix-assisted laser 
desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) are the two 
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most commonly used mass spectrometry instruments for the determination of disulfide 
bonds and identification of related PTMs of a protein.1-4,23-24  Another significant point to 
mention is that by using MS, we can expect relatively high coverage of the protein 
sequence.  High yield protein sequence coverage is an essential key to the 
characterization of a protein because it provides information across the full length of the 
sequence.  This additional information will lead to the complete assignment of the PTM 
sites leading to understanding of protein regulation mechanisms.  Now, researching 
biomarkers of different diseases is very much demanded from the society, detection of 
any kind of sequence modification such as deletion or truncation can give clues to the 
research goal.20  Sequence coverage sometimes helps ascertaining the amount of 
expressed protein as well.  Obtaining high yield sequence coverage depends on many 
small factors for instance, amount of protein, sample preparation and matrix 
adjustments.23  Chemical modification followed by enzymatic digestion of a protein is the 
basic proteomics approach for detecting disulfide bond linkages using MS.4,14,26  MALDI-
TOF MS particularly is useful to detect disulfide bonds because of its high sensitivity and 
relatively simple methodology.  However, it is well known that the sample containing 
multiple cysteines or disulfide bonds is hard to be detected causing the energy absorbance 
or kinetic vibration caused by the multiple cysteines.  Also any salts or contaminants 
including non-cysteine-containing digested fragments lead to poor ionization efficiency 
of the sample.  Due to these factors, only 40-50 % is the range of protein sequence 
coverage by MALDI-TOF MS.  When it is combined with CE (capillary 
electrophoresis)/ESI-TOF MS, sequence coverage can be up to 90 % as it is reported.20,23 
Overall, adjustment of MALDI matrices as well as careful sample preparation would 
greatly contribute to the collection of reliable data and high yield sequence coverage. 
Serum Albumin 
Serum albumin is the most abundant protein in the blood plasma of vertebrates, 
up to 50 % of all protein.27  It is generally rich in cysteines and the molecular weight is 
also relatively large, 67 kDa for human serum albumin.  See Figures 1-1and 1-2 for 3D 
structure and primary sequence. 29-30  Serum albumin is quite hydrophilic and this 
hydrophilicity contributes to keeping up the oncotic (colloid osmotic) pressure.  For 
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example, when a large amount of protein was suddenly lost or body was lacking in 
enough nutrition, the protein level can suddenly be dropped which causes dramatic 
decrease in blood pressure levels.  This condition accumulates fluids in surrounding 
tissues which eventually causes our body to get swollen, known as edema.  Besides 
maintaining oncotic pressure, the free cysteine can specifically transport molecules or 
substances such as ions or variety of drugs to the necessary area.  Because of these 
function, serum albumin is often called “multifunctional plasma transport protein.” 27  
Equine Serum Albumin (ESA) used in this study, contains 607 residues and 35 cysteines. 
See Figures 1-3 and 1-4 for primary and secondary structure of ESA. 28, 31  Furthermore, 
the ESA sequence is 76.1 % and 73.9 % identical to the human serum albumin30 and the 
bovine serum albumin32 respectively (see Figure 1-5 for comparison).28   This high 
sequence similarity also applies to the position and the number of disulfide bonds 
reported.  Both human and bovine serum albumins contain 17 disulfide bonds in similar 
sequence positions.  The three dimensional structure of ESA determined using x-ray 
crystallography with a resolution of 0.27 nm was studied and positions of 17 disulfide 
bonds and 1 free cysteine site were predicted.28  It was also known that ESA contains 3 
phosphorylation sites.  Being very abundant and a cysteine rich protein, ESA was an 
excellent candidate for this study.    
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Figure 1-1  3D structure of Human Serum Albumin by X-ray Crystallography  
Residue 25-609(complexed with thyroxine) 
Red=Cysteines, Green=Cys58 (reported as a free cysteine), Orange=Cys582, 
Purple=Cys583  
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Figure 1-2 Primary sequence of Human Serum Albumin  
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Figure 1-3  Primary structure of ESA  
 
 
 
Figure 1-4  Secondary structure of ESA 
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Equine serum albumin   (highlighted area indicates sequence differences) 
Human  serum albumin   76.1% similarity 
Bovine serum albumin   73.9% similarity    
 
        10          20          30          40          50          60  
MKWVTFVSLL  FLFSSAYSRG  VLRRDTHKSE  IAHRFNDLGE  KHFKGLVLVA  FSQYLQQCPF  
MKWVTFISLL  FLFSSAYSRG  VFRRDAHKSE  VAHRFKDLGE  ENFKALVLIA  FAQYLQQCPF 
MKWVTFISLL  LLFSSAYSRG  VFRRDTHKSE  IAHRFKDLGE  EHFKGLVLIA  FSQYLQQCPF 
 
        70          80          90         100         110         120  
EDHVKLVNEV  TEFAKKCAAD  ESAENCDKSL  HTLFGDKLCT  VATLRATYGE  LADCCEKQEP  
EDHVKLVNEV  TEFAKTCVAD  ESAENCDKSL  HTLFGDKLCT  VATLRETYGE  MADCCAKQEP 
DEHVKLVNEL  TEFAKTCVAD  ESHAGCEKSL  HTLFGDELCK  VASLRETYGD  MADCCEKQEP 
 
       130         140         150         160         170         180  
ERNECFLTHK  DDHPNLPKLK  PEPDAQCAAF  QEDPDKFLGK  YLYEVARRHP  YFYGPELLFH  
ERNECFLQHK  DDNPNLPRLV  RPEVDVMCTA  FHDNEETFLK  KYLYEIARRH  PYFYAPELLF 
ERNECFLSHK  DDSPDLPKLK  PDPNTLCDEF  KADEKKFWGK  YLYEIARRHP  YFYAPELLYY 
 
       190         200         210         220         230         240  
AEEYKADFTE  CCPADDKLAC  LIPKLDALKE  RILLSSAKER  LKCSSFQNFG  ERAVKAWSVA  
FAKRYKAAFT  ECCQAADKAA  CLLPKLDELR  DEGKASSAKQ  GLKCASLQKF  GERAFKAWAV 
ANKYNGVFQE  CCQAEDKGAC  LLPKIETMRE  KVLASSARQR  LRCASIQKFG  ERALKAWSVA 
 
       250         260         270         280         290         300  
RLSQKFPKAD  FAEVSKIVTD  LTKVHKECCH  GDLLECADDR  ADLAKYICEH  QDSISGKLKA  
ARLSQRFPKA  EFAEVSKLVT  DLTKVHTECC  HGDLLECADD  RADLAKYICE  NQDSISSKLK 
RLSQKFPKAE  FVEVTKLVTD  LTKVHKECCH  GDLLECADDR  ADLAKYICDN  QDTISSKLKE 
 
       310         320         330         340         350         360  
CCDKPLLQKS  HCIAEVKEDD  LPSDLPALAA  DFAEDKEICK  HYKDAKDVFL  GTFLYEYSRR  
ECCEKPLLEK  SHCIAEVEND  EMPADLPSLA  ADFVGSKDVC  KNYAEAKDVF  LGMFLYEYAR 
CCDKPLLEKS  HCIAEVEKDA  IPENLPPLTA  DFAEDKDVCK  NYQEAKDAFL  GSFLYEYSRR 
 
       370         380         390         400         410         420  
HPDYSVSLLL  RIAKTYEATL  EKCCAEADPP  ACYRTVFDQF  TPLVEEPKSL  VKKNCDLFEE  
RHPDYSVVLL  LRLAKTYETT  LEKCCAAADP  HECYAKVFDE  FKPLVEEPQN  LIKQNCELFE 
HPEYAVSVLL  RLAKEYEATL  EECCAKDDPH  ACYSTVFDKL  KHLVDEPQNL  IKQNCDQFEK 
 
       430         440         450         460         470         480  
VGEYDFQNAL  IVRYTKKAPQ  VSTPTLVEIG  RTLGKVGSRC  CKLPESERLP  CSENHLALAL  
QLGEYKFQNA  LLVRYTKKVP  QVSTPTLVEV  SRNLGKVGSK  CCKHPEAKRM  PCAEDCLSVF 
LGEYGFQNAL  IVRYTRKVPQ  VSTPTLVEVS  RSLGKVGTRC  CTKPESERMP  CTEDYLSLIL 
 
       490         500         510         520         530         540  
NRLCVLHEKT  PVSEKITKCC  TDSLAERRPC  FSALELDEGY  VPKEFKAETF  TFHADICTLP  
LNQLCVLHEK  TPVSDRVTKC  CTESLVNGRP  CFSALEVDET  YVPKEFNAET  FTFHADICTL 
NRLCVLHEKT  PVSEKVTKCC  TESLVNRRPC  FSALTPDETY  VPKAFDEKLF  TFHADICTLP 
 
       550         560         570         580         590         600  
EDEKQIKKQS  ALAELVKHKP  KATKEQLKTV  LGNFSAFVAK  CCGREDKEAC  FAEEGPKLVA  
SEKERQIKKQ  TALVELVKHK  PKATKEQLKA  VMDDFAAFVE  KCCKADDKET  CFAEEGKKLV 
DTEKQIKKQT  ALVELLKHKP  KATEEQLKTV  MENFVAFVDK  CCAADDKEAC  FAVEGPKLVV 
 
SSQLALA  
AASQAALGL      
STQTALA       
   
 
Figure 1-5  Sequence comparison between Equine (black), Human (blue), and 
Bovine (red) serum albumin 
Differences between three sequences are highlighted in grey 
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Research Outline 
In this study, several kinds of in-gel chemical modification and enzyme 
digestion were performed, followed by MALDI-TOF MS to analyze the disulfide bond 
combinations present in fresh ESA.  In order to improve quick and easy disulfide bond 
mapping methodologies and also to achieve high yield protein sequence coverage using 
MS, we optimized the protocol by chemically labeling the cysteines and also used a new 
type of matrix.  Nearly 90 % of sequence coverage was obtained by single enzyme 
digestion after reduction and carboxymethylation of sample while two enzyme combined 
data showed up to 92 % sequence coverage.  The possibility of other PTMs such as 
glycosylation and phosphorylation, in the ESA sample, were also investigated using a 
proteomics approach. 
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 CHAPTER 2 - Experimental Procedure 
Sample Separation and Confirmation 
Fresh equine serum (KSU ES) was kindly provided from Dr. James Lillich, 
Kansas State University College of Veterinary Medicine, collected during a routine 
check-up.  The sample was obtained from a healthy, 14 years old male Equus caballus 
(horse), weigh 450 kg.  SDS-PAGE and HPLC were used to compare the fresh sample 
against purchased equine serum (Sigma ES) (Sigma-Aldrich, St. Louis, MO).   
 SDS-PAGE 
Electrophoresis was carried out using a SDS-PAGE apparatus and reagents 
(Invitrogen, Carlsbad, CA) and by following the protocol as described below.  KSU and 
Sigma ES 1.0 μL each was diluted with 9.0 μL of Novex Tricine SDS sample buffer, 
followed by the heat denaturation at 85 °C for 2 minutes.  Prepared samples 10.0 μL 
along with 10.0 μL of Mark 12 unstained molecular weight standard were applied to the 
each well in the 10-20 % Tricine gel 1.0 mm, 10 well which was pre assembled with 
500.0 mL of Novex Tricine SDS running buffer.  The prepared gel was run for 90 
minutes at a constant 125 V followed by staining with Coomassie blue R-250 (Bio-Rad, 
Hercules, CA) and then destained with deionized distilled water (D.D.water).   
HPLC 
An HPLC column, Hydro-RP (reverse phase) 80 A, 150 X 4.60 mm 4 micron 
column (Phenomenex, Torrance, CA) was equilibrated with 0.1 % trifluoroacetic acid 
(TFA) for 3 hours prior to the experiment.  Both KSU and Sigma ES were diluted with 
D.D.water to 1/10 of the original concentration.  The diluted sample 20.0 μL was injected 
into the System Gold HPLC (Beckman, Fullerton, CA) with pre equilibrated Hydro-RP 
column and run with a mobile phase, D.D water containing 0.1 % TFA, for 30 minutes  
while the absorbance was monitored at 215 nm.   
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Protein Concentration Determination 
KSU ES was diluted 1/5, 1/10, and 1/100 of the original concentration using 
D.D.water.  To the 2.0 μL of diluted sample, 13.0 μL of D.D.water and 5.0 μL of the SDS 
sample buffer were added to make a total volume of 20.0 μL in each sample.  Bovine 
serum albumin (BSA) (Pierce, Rockford, IL) standard, 2.0 mg/mL, was diluted to a 
concentration of 0.2 mg/mL with D.D.water.  Sample buffer 5.0 μL was added to 0.5, 1.0, 
5.0, and 10.0 μL of diluted BSA standard.  D.D.water was added into the BSA mixture to 
make a total volume of 20.0 μL in each sample mixture.  A total 20.0 μL of prepared 
serum and BSA standards were loaded into the prepared tricine gel.  The electrophoresis 
was performed by following the standard protocol using Invitrogen SDS-PAGE apparatus 
as described in the previous section.  UN-SCAN-IT gel software version 6.1 (Silk 
Scientific, Orem, UT) was used to determine the density of each band after scanning the 
completed gel using a ScanJet ADF (Hewlett Packard, Palo Alto, CA).  The prescribed 
dilution of the BSA concentration standards were plotted in the x-axis and average pixels 
of the corresponding bands were plotted in the y-axis to make a standard calibration 
graph.  This standard calibration graph was later used to determine the concentration of 
equine serum albumin.     
Chemical Modification 
6-Iodoacetamido Fluorescein (6-IAF) 
The dye 6-Iodoacetamido fluorescein (6-IAF, molecular weight = 515.26) was 
purchased from Molecular Probes (Invitrogen, Carlsbad, CA).  Freshly obtained KSU ES 
(native), 50.0 μL, was mixed with equal volume of 5 mM of 6-IAF stock solution (2.58 
mg/mL 50 % DMF in D.D.water.) and placed in 4 °C for an overnight reaction in the 
dark (more than 10 fold excess 6-IAF to a free cysteine).  Unreacted 6-IAF was removed 
by using a Sephadex G-25 column (Pharmacia Fine Chemicals, Piscataway, NJ) using 
D.D.water.  SDS-PAGE and UV-visible spectrophotometer were used to confirm the 
attachment of 6-IAF to the free cysteine site in the serum.  Purified sample was covered 
and kept in 4 °C.    
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6-IAF Label Confirmation and Separation of ESA Using SDS-PAGE 
SDS sample buffer, 10.0 μL, was added to 10.0 μL of the collected 6-IAF labeled 
serum fractions and then the mixture was applied to the SDS-PAGE using the standard 
protocol.  After running, the gel was first rinsed with D.D.water to wash out the SDS and 
6-IAF.  It was then visualized using a Typhoon 9410 Imager (Amersham Biosciences, 
Piscataway, NJ), which was set at 488 nm and 520 nm for the excitation and emission 
wavelengths, respectively.  Image Quant TL 7.0 software (GE Healthcare bioscience AB, 
Uppsala, Sweden) was used for the image analysis.  The sample was prepared for the in-
gel digestion by following the standard protocol; 6-IAF attached serum albumin band 
from completed gel was cut into pieces and washed with 50 % acetonitrile twice for 15 
minutes each.  It was then frozen and dried using FreeZone 2.5Plus lypholizer 
(LABCONCO, Kansas City, MO).    
6-IAF Label Confirmation Using UV-visible Spectrophotometer 
Purified 6-IAF labeled equine serum fractions were placed into a quartz cuvette 
with 10 mm pathlength (Uvonic Instruments, Inc., Plainview, NY) and scanned over the 
range of 200-700 nm, using a Cary 50 Bio UV-visible spectrophotometer (Varian, Palo 
Alto, CA) and Cary Win UV software (Varian, Palo Alto, CA).  The blank used in this 
experiment was prepared by taking a 1/100 diluted equine serum in D.D.water.        
 
Carboxymethylation  
The freshly obtained KSU ES was treated with iodoacetamide (IAA, molecular 
weight = 184.96).  To 10.0 μL of the KSU ES (native) sample, 90.0 μL of 50 mM IAA 
(Fluka, Sigma-Aldrich, St. Louis, MO) in 4 M urea (Invitrogen, Carlsbad, CA) was 
added.  It was then incubated at the room temperature for 1 hour under dark (more than 
500 fold excess IAA to a free cysteine).  The incubated sample, 1.0 μL, was mixed with 
9.0 μL of SDS sample buffer and applied to the tricine gel followed by the application of 
standard protocol.  The serum albumin band was cut from the stained gel and prepared 
for in-gel enzyme digestion.  For reducing the sample, the unmodified serum albumin 
band from the completed SDS-gel was excised and cut into smaller pieces.  Pierce In-Gel 
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Tryptic Digestion Kit (Thermo scientific, Rockford, IL) was used for in-gel enzymatic 
digestion by following the experimental procedure described here.  The gel pieces were 
first destained with 200.0 μL of destaining solution, 50 % acetonitrile, and then incubated 
in the room temperature for 30 minutes.  This step was repeated several times to 
completely remove the staining dye.   After the destaining solution was removed, 30.0 μL 
of 50 mM Tris (2-carboxyethyl) phosphine Hydrochloride 33 (TCEP·HCl, structure and 
chemical equation are shown in Figure 2-1 34) was added and incubated for 10 minutes at 
60°C for in-gel reduction (more than 100 fold excess to 17 disulfide bonds).  The 
reducing solution was removed and 30.0 μL of 100 mM IAA in digestion buffer (more 
than 500 fold excess to 35 cysteines) was added to the sample followed by 1 hour of 
incubation at room temperature in dark for in-gel alkylation (carboxymethylation).  The 
alkylation solution was removed and the sample was washed twice, 30 minutes each, 
with 200.0 μL destaining buffer to remove excess IAA.  It was then prepared for the in-
gel digestion by lypholyzation.   
 
Figure 2-1  Tris(2-carboxyethyl)phosphine (TCEP) structure and chemical equation  
 
 
Proteolytic Digestion 
Trypsin Gold, mass spectrometry grade (Promega, Madison, WI) 10 ng/μL in 50 
mM ammonium bicarbonate (Fluka/Sigma-Aldrich, St. Louis, MO), 30.0 μL, was added 
to the prepared gel pieces followed by the addition of 30 μL of digestion buffer (50 mM 
ammonium bicarbonate).  The sample was then incubated for overnight at 30 °C.  The 
same procedure was repeated for the digestion using the endoproteinase Lys-C (Roche, 
Mannheim, Germany) 10 ng/μL in D.D.water.  The digested sample was extracted from 
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the gel pieces by first transferring the digestion mixture to a new tube, then adding 100.0 
μL of 0.1 % TFA in 50 % acetonitrile extraction solution.  The sample was again 
incubated for 30 minutes at the same temperature for further extraction.  The extraction 
solution was removed and combined with previously extracted digest mixture.  This step 
was repeated one more time.  The combined solution was freeze dried for 3 hours or until 
the sample was completely dried.   
MS and MS/MS Measurements 
Matrices; 2,5-Dihydroxybenzoic acid (DHB) (Sigma-Aldrich, St. Louis, MO) 30 
mg and α-Cyano-4-hydroxycinnamic acid (CCA) 97 % (Sigma-Aldrich, St. Louis, MO) 
10 mg were each dissolved in 1.0 mL of 33 % acetonitrile/ 0.1 % TFA.  Another matrix; 
1,5-Diaminonaphthalene (DAN) (Fluka/Sigma-Aldricha, St. Louis, MO) 10 mg was 
dissolved in 1.0 mL 50 %  acetonitrile.  DAN was prepared just before mixing with the 
sample and must be shielded against light to avoid auto oxidation.  The chemical 
structures of all three matrices are shown in Figures 2-2 though 2-4.  DAN is a new type 
of matrix known to have a reducing capability with addition of laser energy from the MS 
instrument.25  The reducing capability of DAN was tested using a synthesized 
vasopressin by mixing sample and prepared matrix in 1:1 ratio.  Vasopressin is a peptide 
hormone containing 2 cysteines, 1 disulfide bond, and synthesized in the magonocellular 
cells of brain to be released into the blood stream.  Its main function is to regulate the 
water retention in the body leading to the control of urine levels.35  For the MS 
measurements of ESA, the dried extracted sample was first resuspended in 10.0 μL of 
0.1 % TFA, then 1.0 μL of resuspended sample mixture was mixed into 5.0 μL of 
prepared DHB or 1.0 μL of DAN.  2.0 μL of sample/matrix mixture was applied to a 
MTP 384 massive target plate (Bruker Daltonics GmbH, Billerica, MA) and measured 
using positive ion reflector mode.  The Ultraflex II TOF/TOF mass spectrometer, Flex 
control-compass 1.1 data acquation 3.0, Flex analysis 3.0, Bio Tools 3.0 software were 
purchased from Bruker Daltonics GmbH (Billerica, MA) and used for mass spectral 
measurement, data acquisition and analyses.   With the use of peak detection, algorithm 
centroid monoisotopic, masses in the range of 0-5000 Da were assigned with the signal to 
noise threshold fixed to 5.   
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The MS/MS analyses were performed by the MALDI LIFT-TOF/TOF MS 
technique which increases the ion potential energy.  Using laser-induced-dissociation 
(LID), the sequence of produced peptide fragments within the precursor ion can be easily 
assigned.  The MS measurements were externally calibrated using Peptide Calibration 
Standard I (Bruker Daltonics GmbH, Billerica, MA).  Mixture of monoisotopic ion mass 
[M+H]+ in the standard includes 757.40 Da (Bradykinin 1-7), 1046.54 Da (Angiotensin 
II), 1296.68 Da (Angiotensin I), 1347.47 Da (Substance P), 1619.82 Da (Bombesin), 
2093.09 Da (ACTH 1-17), 2465.20 Da (ACTH 18-39), and 3147.47 Da (Somatostatin 
28).  Additional internal calibration was also achieved in the flex analysis 3.0 by taking 
pre-calculated monoisotopic ion mass [M+H]+ of the digested ESA fragments.  
Background subtraction or smoothing of acquired data was not performed in these data 
sets.   
 
 
Figure 2-2   Chemical structure of 2,5-Dihydroxybenzoic acid (DHB) 
 
 
 
Figure 2-3   Chemical structure of α-Cyano-4-hydroxycinnamic acid (CCA) 
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Figure 2-4   Chemical structure of 1,5-Diaminonaphthalene (DAN) 
 
PTM Investigation 
Glycosylation Detection using Glycoprotein Staining Kit 
GelCode Glycoprotein Staining Kit was purchased from Pierce (Rockford, IL).  
Horseradish Peroxidase (HP) and soybean trypsin inhibitor (TI) (included in the kit) were 
used for positive and negative controls respectively.  Both dried controls were 
resuspended by adding 0.5 mL of D.D.water to make 2 mg/mL solution.  It was then 
diluted to make a concentration of 1 mg/mL using the SDS sample buffer.  1.0 μL of the 
equine serum was diluted with 10.0 μL of D.D.water and 22.0 μL of SDS sample buffer 
to make 1 ug/μL solution.  BSA (used in the protein concentration determination 
experiment) was also diluted with SDS sample buffer to make 1 mg/mL solution.  Both 
5.0 and 10.0 μL of each control and prepared sample were applied to the tricine gel.  The 
SDS-PAGE standard protocol previously described was used to carry out electrophoresis.  
The completed gel was stained by following the direction briefly described here.  The gel 
was fixed in 50 % methanol, and then washed with 3 % acetic acid.  After removing the 
wash solution, the oxidizing solution (include in the kit) was added to the gel and gently 
agitated for 15 minutes.  To the gel, 3 % acetic acid was added again to gently wash the 
gel for a few times.  The glycoprotein staining reagent (included in the kit) was added 
which react only with the glycoproteins.  After discarding the staining solution, a 
reducing solution (include in the kit) was added.  Finally, the gel was washed with 3 % 
acetic acid and D.D.water then scanned using Epson TWAIN5 USB Scanner.   
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 Phosphorylation Detection Using Phosphoprotein Staining Kit 
The Pro-Q Diamond Phosphoprotein Gel Stain Kit was purchased from Molecular 
Probes (Invitrogen, Carlsbad, CA).  The same tricine gel which was used for the 
glycoprotein investigation was again used for this experiment.  The completed gel was 
stained by following the direction briefly described here.  The gel was fixed with the 
fixing solution; 50 % methanol/ 3 % acetic acid followed by rinsing with D.D.water.  
Then Pro-Q Diamond stain was added to the gel followed by 1 hour incubation in dark.  
Destaining solution was prepared by mixing 20 % acetonitrile and 50 mM sodium acetate 
at pH 4.  The stained gel was transferred into the destaining solution for three times to 
remove the background, and then the gel was once again washed with D.D.water for 
twice.  The stained gel was visualized using Typhoon 9410 with 532 nm excitation 
wavelength and 560 nm long pass emission wavelength.  Image Quant TL 7.0 software 
was used for further image analysis.   
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 CHAPTER 3 - Results 
Sample Confirmation 
The KSU and Sigma ES showed identical bands based on the SDS-PAGE 
analysis (Figure 3-1).  Serum albumin showed a distinctively broad and diffused band at 
approximately 50 kDa based on the comparison with a GDH (glutamic dehydrogenase = 
55.4 kDa) which is contained in the molecular marker.  The HPLC data of the diluted 
samples showed almost identical peaks as that shown in the Figure 3-2.  The main peak 
for both samples appeared approximately 14 minutes after the sample was injected.  KSU 
serum showed more small peaks than the Sigma sample in the period between 7 and 10 
minutes and again after 17 minutes.  
 
 
Figure 3-1   Sample confirmation by SDS-PAGE 
BSA= Bovine Serum Albumin, GDH= Glutamic Dehydrogenase, LDH= Lactate 
Dehydrogenase, CAH= Carbonic Anhydrase, TI= Trypsin Inhibitor 
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Figure 3-2   Sample confirmation by HPLC 
Dotted line = KSU ES 
Solid line = Sigma ES 
 
 
Protein Concentration Determination 
The protein concentration determination standard calibration graph (Figures 3-3 
for the gel image, 3-4 for the data table, and 3-5 for the graph) was made by taking μg of 
standard BSA along the x-axis and average number of pixel on y-axis.   A best fit line 
was calculated as y = 13.016x + 1.0665 with the R² value of 0.9982 as shown in the 
Figure 3-5.  A 1/100 diluted equine serum albumin band, far right on the Figure 3-3, was 
used to find the concentration of the sample.  The protein concentration of the ESA 
sample was determined to be 33 mg/mL.  Since the molecular weight of ESA was known 
as 68,554 g/mol, molar concentration of the sample was calculated to be 480 μM.  Based 
on these calculations, the concentrations of disulfide bond and cysteine were determined 
to be 8.16 nmol and 16.8 nmol in 1μL of serum, respectively.    
 
21 
 
Figure 3-3   Protein concentration determination gel image 
 
BSA (μg) Avg.pixel   
0.1 1.76   
0.2 4.23  ESA concentration: 33 mg/mL  
1 14.23  17 disulfide bonds/mol→ 8.16 nmol disulfide bonds  
2 27  35 cys/mol → 16.8 nmol cys  
Figure 3-4   Protein concentration determination data table 
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Figure 3-5   Protein concentration standard graph 
BSA in μg (x-axis), Average number of pixels from the densitometer (y-axis) 
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 Chemical Modification 
6-Iodoacetamido Fluorescein  
Figure 3-6 represents an image of a tricine gel containing 6-iodoacetamido 
fluorescein (6-IAF) labeled equine serum after it was purified from the excess 6-IAF.  
The chemical structure of the 6-IAF attachment to the free cysteine is shown in the 
Figure 3-7.  The 6-IAF labeled serum albumin band is in yellow.  Weak yellow bands are 
also visible in lower (< 5 kDa) and higher (~97 kDa) molecular weight region.  6-IAF 
modification of the serum was also confirmed by scanning sample from 200 to 700 nm 
using spectrophotometer.  Figure 3-8 shows the spectrum of scanned data.  The blue line 
represents the blank, 1/100 diluted unmodified equine serum in D.D.water, and the 
yellow line represents 6-IAF labeled sample.  One clear broad peak was observed near 
500 nm region.  The λmax of the sample was determined to be 0.347 at 484.1 nm.   
 
 
 
Figure 3-6   6-IAF labeled ESAox gel image 
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Figure 3-7   Chemical equation for the 6-IAF labeling of cysteine residue 
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Figure 3-8   UV-visible wavelength scan spectrum of 6-IAF labeled ES 
 
Carboxymethylation  
Both IAA labeled and unmodified equine serum sample were run in the SDS gel 
as shown in the Figure 3-9.  The large diffused ESA bands are visible in the first and 
third lanes.  The molecular weight of the sample is estimated around 50 kDa based on the 
molecular marker applied in the middle lane (GDH = 55.4 kDa).  Figure 3-10 shows the 
chemical equation of carboxymethylation of the cysteine.  Visible changes due to this 
chemical modification were not observed from the gel image.  The ESA band (indicated 
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by an arrow) from the unmodified equine serum (ES only) was later cut out, destained, 
reduced and carboxymethylated within the gel.   
   
 
Figure 3-9   IAA labeled ES gel image 
 
 
 
 
 
Figure 3-10   Chemical equation for the carboxymethylation with cysteine residue 
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 Proteolytic Digestion 
The expected disulfide bonded peptides produced by the enzymatic digestion are 
summarized in the Table 3-1 and 2.  The ESAox (oxidized = native equine serum 
albumin) produces 9 disulfide peptide clusters using trypsin and 8 with the protease Lys-
C.  The disulfide bonded peptides included intrapeptide bond (blue), interpeptide bond 
(red), and a combination of both.  Digestion of the ESAred (reduce equine serum albumin) 
using trypsin or Lys-C produced 81 and 63 fragments, respectively.   
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Tryptic fragment Fragment/Expected mass
 
Table 3-1   Expected disulfide bonded peptide clusters by trypsin digestion 
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Lys-C fragment Fragment/Expected mass
 
 
Table 3-2  Expected disulfide bonded peptide clusters by Lys-C digestion 
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MS and MS/MS Analysis 
DAN (1,5-Diaminonaphthalene) Reduction Potential Confirmation 
All of the following MS analyses were achieved by taking an average of 1000 sets 
of calibrated data.  The reducing capability of DAN was initially tested with a 
synthesized vasopressin as shown in the Figure 3-11.  The oxidized vasopressin was first 
measured using the matrix CCA with the detected peaks indicated in blue on the Figure 
3-12.  The molecular ion (M+H)+  of the oxidized vasopressin is 1085.4 m/z and was 
observed as the highest peak in the full spectrum (inset in, top right corner).  Vasopressin 
with the deletion of C-terminus glycine had a molecular ion of 1028.4 m/z which was 
also detected (inset in, top left corner) in the same spectrum.  The sample reduced by 
DAN should gain 2 protons which shifts the molecular ions to be 1087.4 m/z and 1030.4 
m/z for glycine deleted vasopressin.  Both of those two peaks (indicated in red) were 
observed with high intensities, up to 105 scale.  A peak of non-reduced vasopressin was 
observed however, which overlapped with the oxidized vasopressin peak. 
 
 
 
Figure 3-11   Vasopressin sequence and molecular weight 
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Figure 3-12   MS spectra of Vasopressin CCA/DAN 
 
 
Trypsin Digested Fragments 
DHB (2,5-Dihydroxybenzoic acid) 
Figure 3-13 shows the trypsin digested fragments of IAA labeled ESAox using 
DHB as a matrix.  The IAA-labeled free cysteine fragment (residues 45-65), [M+H]+ = 
2478.2 m/z, was detected.  Peptide clusters Tryp 1 (1 miscleavage), 4, 5, 7, and 8 from 
the Table 3-1 were also detected with smaller intensities.  The total sequence coverage of 
this spectrum was calculated to be 47.0 % as indicated in blue in the Figure 3-14.  The 6-
IAF labeled ESAox, [M+H]+ = 2809.2 m/z , was also detected using DHB as shown in the 
Figure 3-15.  The 6-IAF labeled ESA spectrum had a reduced intensity (103) compared to 
the IAA labeled ESA spectrum (104).  Also, 6-IAF labeled ESA had lesser number of 
peaks, particularly larger than 2000 m/z molecular ion peaks were rarely observed.  IAA 
labeled (carboxymethylated) ESAred was measured using DHB (Figure 3-16) and showed 
peaks of higher intensities throughout the entire spectrum.  Total sequence coverage of 
the reduced sample was determined to be 78.3 % (Figure 3-18) after MS/MS 
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measurement was applied.  The intensity of the reduced sample was generally higher 
(105) compared to the oxidized sample.    
Additionally, produced fragment from the ESAred peak 1231 m/z was analyzed 
using MS/MS method.  Precursor ion 1231.5 m/z had a possibility of being one of the 
following fragments; IAA labeled CSSFQNFGER (residues 223-232) or ACCDKPLLQK 
(residues 300-309).  After the analysis of precursor ion 1231 m/z spectrum, SFQNF 
peptide sequence was successfully identified.  This data verified the peak 1231 m/z to be 
IAA labeled CSSFQNFGER (residues 223-232), as shown in the Figure3-17.    
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Figure 3-13   MS spectra of IAA labeled ESAox/DHB 
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Figure 3-14   Sequence coverage of IAA labeled ESAox by trypsin 
Blue = Detected sequence, Highlighted C = Cys 58 (free cys) 
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Figure 3-15   MS spectra 6-IAF labeled ESAox/DHB MS spectra 
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Figure 3-16   MS spectra of carboxymethylated ESAred/DHB  
Peak 1231 is indicated in red square, 2 IAA labeled fragments are possible 
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Figure 3-17   MS/MS spectra of peak 1231 
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Figure 3-18   Sequence coverage carboxymethylated ESAred by trypsin 
Blue = Detected sequence, Highlighted C = Cys 58 (free cys) 
 
 
 
 
DAN 
Trypsin digested ESAox fragments were analyzed by the MS using DAN as a 
matrix which has a reducing capability upon increased laser energy from the MS 
instrument.  Figure 3-19 shows MS spectra of IAA labeled ESA cluster Tryp8 with DHB 
(orange) and DAN (green).  Tryp8 is composed of 3 digestion fragments which are linked 
together with 2 disulfide bonds.  The total molecular ion of this cluster was 3658.8 m/z 
and it was measured using DHB as shown in the right bottom corner of the Figure.  
Reduced fragments ions appeared using DAN and each are indicated in the corresponding 
colors (841.4 in purple, 997.4 in lime green, and 1823.9 in light blue).  Similar analysis 
was performed to the other tryptic peptide clusters as shown in the Appendix A, Figures 
A-1 through A-7.    
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Figure 3-19   MS spectra of Tryp8 
Orange = MS spectra of the ESAox  
Green = MS spectra of the ESAred (with DAN).  
Pink = Tryp8 peptide cluster (3658.8 m/z) 
3 reduced fragments are shown with corresponding colors 
 
Lys-C Digested Fragments 
DHB 
The IAA labeled ESAox was first analyzed with DHB as shown in the Figure 3-20.  
An IAA labeled free cysteine fragment as well as the disulfide bonded peptide clusters 
Lysc2, 4, and 5 (from the Table 3-2) were detected.  Total sequence coverage including 
free cysteine fragments was 54.0 % (Figure 3-21).  Carboxymethylated ESAred was also 
measured using DHB and produced 89.1 % sequence coverage with higher MS signal 
intensities (105) as shown in the Figures 3-22 and 23.  The MS spectrum of ESAred 
peptides had a higher intensity throughout the entire spectrum.  The spectrum of IAA 
labeled ESAox (Figure 3-20) was observed with lesser intensity (104) and also noticeable 
intensity gaps were seen between peaks of disulfide bonded peptide clusters and non-
disulfide bonded fragments.  For example, disulfide bonded clusters Lysc4 and Lysc5 had 
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intensities of approximately 0.2 x 104 a.u. (arbitrary unit) while non-disulfide bonded 
fragments such as 1145.365 m/z and 1994.701 m/z  had intensities of 2.0 X 104 a.u.   
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Figure 3-20   MS spectra of IAA labeled ESAox /DHB  
 
 
 
 
Figure 3-21   Sequence coverage of IAA labeled ESAox by Lys-C digestion 
Red = Detected sequence, Highlighted C = Cys 58 (free cys) 
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Figure 3-22   MS spectra of carboxymethylated Lys-C digested ESAred /DHB  
 
 
 
Figure 3-23   Sequence coverage of IAA labeled ESAred by Lys-C  
Red = Detected sequence, Highlighted C = Cys 58 (free cys) 
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 DAN 
The Lys-C digested disulfide bonded clusters were measured using the MS with 
DAN as a matrix.  Figure 3-24 shows the MS spectra of IAA labeled peptide cluster 
Lysc7.  The Lysc7 is the largest disulfide bonded peptide cluster with a [M+H]+ = 
9397.56 m/z in the native state.  It contains 3 interpeptide and 1 intrapeptide disulfide 
bonds.  The oxidized sample peak with DHB (pink) was not detected, however, all 4 
fragments (indicated in corresponding color) were observed.  Peak 2802.068 m/z 
indicates intrapeptide bond and after reduction of the bond with DAN, a 2 mass unit 
shifted peak was seen.  Analysis was similarly done to the rest of peaks as shown in the 
Appendix B, Figures B-1 though B-5.   
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Figure 3-24   MS spectra of IAA labeled ESAox Lysc7  
9397 m/z peak = not detected (not shown in the Figure above) 
4 separated fragments = purple, orange, green, and light blue  
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 PTM Investigation 
 Glycosylation Detection  
The glycosylation state of the sample was investigated against both positive and 
negative controls, as well as BSA using a glycoprotein staining kit.  Presence of 
glycoprotein in gel was indicated with pink color stain.  Figure 3-25 shows a comparison 
between samples loaded in different amounts and stained with Coomassie or the 
glycoprotein staining kit.  Image on the left shows the gel stained with R-250 Coomassie 
blue while the image on the right shows the same gel which is stained with the 
glycoprotein staining kit.  As a positive control, the HP (horse radish peroxidase) band 
was observed around 48 kDa in both gels while the negative control TI (soybean trypsin 
inhibitor) band was seen only in the Coomassie stained gel with molecular weight of 
nearly 16 kDa.  The KSU ES was also loaded into the gel and the regular bands were 
seen with Coomassie staining, though no ESA band was observed in the glycoprotein 
stained gel.  Some of the higher molecular weight bands (66, 97, and 120 kDa) within the 
serum sample were observed in the glycoprotein stained gel.  The BSA band was also not 
visible in the glycoprotein stained gel.   
Phosphorylation Detection 
Phosphoprotein detection was performed using the phosphoprotein gel staining kit 
on the same gel used for the glycoprotein detection.  Figure 3-26 shows Coomassie 
stained gel on the left and phosphoprotein stained gel on the right.  ESA bands were 
observed in the phosphoprotein stained gel as indicated by the arrows.  Compare to the 
Coomassie stained gel, the size of the ESA band is much narrower in the phosphoprotein 
stained gel.  The HP and TI, positive and negative control, bands were also visible in this 
experiment.  The HP bands were significantly stained compared to the TI bands.  BSA 
bands were slightly visible in the phosphoprotein stained gel.   
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Figure 3-25   Glycoprotein stained gel image 
Glycoprotein gel image (right), Coomassie stained gel image (left) 
+ Positive control = HP (horseradish peroxidase) 
– Negative control = TI (soybean trypsin inhibitor) 
Different amount of controls, equine serum (ES), and bovine serum albumin (BSA) were 
loaded along with the molecular marker 
 
 
 
Figure 3-26   Phosphoprotein stained gel image 
Phosphoprotein gel image (right), Coomassie stained gel image (left)  
Same gel was used as described in the Figure 3-25.  Arrow indicates ESA band. 
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 CHAPTER 4 - Discussion 
Sample Confirmation 
The distribution of the bands from the SDS-PAGE (Figure 3-1) and peak pattern 
from the HPLC (Figure 3-2) of KSU ES were virtually identical to the ones seen with the 
Sigma ES.  These results confirmed that the band identified as ESA from the K-State 
veterinary medicine was the protein of interest.  The Sigma ES was essentially used to 
standardize the experimental procedures for KSU ES analyses.   
Protein Concentration Determination 
Based on the graph shown in the Figure 3-5 along with some additional 
calculations, the concentration of the ESA in the KSU ES sample was determined to be 
33 mg/mL.  The distinctive wide band observed in the SDS-PAGE (Figure 3-3) 
confirmed a high abundance level of the albumin within the serum albumin sample.  The 
sequence based molecular weight of the ESAox is 68,554.3 Da while observed molecular 
weight which is based on the molecular weight standard was approximately 50 kDa.  This 
molecular weight shift can be explained by the presence of disulfide bonds.  The sample 
applied to the SDS-PAGE was heat denatured but not reduced in order to maintain the 
native disulfide pattern of the ESA.  Due to the presence of 17 disulfide bonds in the 
ESA, the protein could only be denatured up to certain level, possibly preventing the SDS 
from fully interacting with the protein and increasing its net charge.  In other words, the 
presence of this particularly large number of the disulfide bonds preserves a tightly 
folded structure which affects its mobility in the SDS gels.  This change in the size of 
protein could perhaps lead to the observed molecular shift in the gel.  To confirm this 
hypothesis, a reduced ES sample was applied to the SDS gel.  The ESAred band was 
shifted up to that of the BSA standard 66.3 kDa (gel image not shown).  Based on the 
observed concentration of ESA, the calculated amount for the cysteine is 16.8 nmol, and 
8.16 nmol for the disulfide bonds.   
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 Chemical Modification 
6-Iodoacetamido Fluorescein  
The broad yellow bands present in Figure 3-6 confirm the attachment of the 6-
IAF to the free cysteine in the ESA.  A few other proteins within the serum also appear to 
contain free cysteines as some fainter yellow bands were observed at a higher (97 kDa) 
and lower (< 5 kDa) molecular weights based on the molecular weight standard.  A clear 
absorbance peak around 500 nm in the visible/UV spectrum (Figure 3-8) also indicated 6-
IAF was attached to the free cysteine in the serum.  This covalent bond between free 
sulfur of the cysteine side chain and carbon of the 6-IAF is highly stable.  Therefore, once 
the 6-IAF is attached to the free cysteine, manipulation of the sample will not alter this 
modification even with a change of its surrounding conditions (Figure 3-7 for chemical 
equation).  After the electrophoresis of 6-IAF labeled serum was finished, the SDS gel 
needed to be rinsed several times with D.D.water to all remove excess dye present in the 
lower portion of the gel.  Labeling the protein using fluorescein is a practical method for 
protein analysis not only due to its high stability, but also completion of the modification 
can visually be assessed.       
Iodoacetamide  
The IAA labeled and non-modified equine serum had the identical bands in SDS 
PAGE as shown in the Figure 3-9.  For the native (oxidized) sample, IAA should only 
modify the single free cysteine.  When the sample was reduced using more than 100 fold 
of TCEP and quickly treated with more than 500 fold of IAA, all of the cysteine residues 
should be modified and therefore unable to reform disulfide bonds.  Due to this chemical 
modification of the cysteines, the protease digestions were carried out much more 
effectively by increasing the enzyme’s accessibility to the preferred cleavage sites.  By 
generating small peptide fragments and eliminating the disulfide linkage, performance in 
MS is improved due to the greater ionization of digested fragments which in turn leads to 
the higher sequence coverage in the MS spectrum.   
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IAA labeling of the protein is a very important tool for peptide mapping along 
with the labeling with fluorescein.  It covalently alkylates free sulfurs and therefore 
blocks any unwanted oxidations that would interfere which interpreting the data.  As 
shown in the Figure 3-10, when IAA attaches to the free sulfur, both the I- and H+ are 
products of the reaction.  This modification causes the cysteine containing fragments to 
gain 57 molecular mass per cysteine and this should be small enough compound to go 
and interact with a tightly folded protein to label any free sulfhydryl group in the native 
protein.  Labeling the fully reduced protein helps to make sure that the protein will fully 
unfold during the proteolytic digestion process.            
 
Proteolytic Digestion 
The chemically modified samples were digested with two different enzymes; 
trypsin and Lys-C.  The units of enzymes as well as the wash and extraction procedures 
were identical for both enzymes.  Comparing these two enzymes, they both have similar 
activities and cleavage preferences.  Trypsin cleaves protein at a C-terminus of both 
arginines and lysines while Lys-C specifically cleaves only at a C-teminus of lysines.  
These enzymes both have pH optima of 7 to 9 and are mostly resistant to 0.1 % SDS, 1M 
urea, or up to 10 % acetonitrile (Product information from Promega and Roche).  
However a notable difference is the cost for conducting a single experiment.  In our 
protocol, it only costs $ 0.19 for trypsin while costs $5.52 for Lys-C to digest the same 
sample.  This significant difference in cost between two enzymes seems to reflect the 
percent sequence coverage obtained for ESA sample.  Besides trypsin and Lys-C, 
chymotrypsin was used either independently or in combination with the other enzymes.  
However, due to lack in the specificity of chymotrypsin, satisfactory data were not 
obtained.   
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MS and MS/MS Analysis 
 DAN Reducing Potential Confirmation 
Using the synthesized vasopressin, the reducing capability of DAN was tested. 
Synthesized vasopressin was first analyzed with the MS using CCA as a matrix.  The 
oxidized vasopressin spectrum (blue line) in the Figure 3-12 indicated a peak at 1085.4 
m/z with the highest intensity.  Vasopressin was then analyzed using DAN to confirm its 
reducing capability.  The MS spectrum obtained using the DAN (red line) showed a peak 
shift (to the higher mass) between the oxidized and reduced vasopressin. The reduced 
vasopressin had a molecular ion of [M+H]+ = 1087.5 which also produced the highest 
intensity peak in the spectrum.  Although the majority of the peak indicated a reduced 
vasopressin, a minor oxidized vasopressin peak was still detected.  Based on this 
experiment, reducing capability of DAN was verified but not at 100 % efficiency for this 
sample.  MS measurements using DAN as the matrix can be challenging mainly due to its 
preparation.  DAN must be prepared immediately before applying to the sample plate 
because it quickly self-oxidizes within the solution.  Also after the DAN solution was 
prepared, it needed to be kept in dark to avoid chemical reaction caused by exposure to 
light.  The crystal of the peptide-DAN mixture formation on the MALDI target plate also 
contributes to improved sample ionization. 
Analysis of Digested Fragments 
MS Analysis Using DHB 
As shown in the Figure 3-13, 5 out of 9 trypsin digested disulfide bonded 
oxidized peptide clusters (from Table 3-1) were found using DHB.  This result generates 
only a total ESAox sequence coverage of 47.0 % including IAA/6-IAF labeled free 
cysteine fragment.  IAA and 6-IAF labeled cysteine (Cys58) peaks, [M+H]+ = 2478.2 m/z 
and [M+H]+ = 2809.2 m/z, were detected thus confirming each of the two different 
chemical modifications.  The 6-IAF labeled cysteine fragment (Figure 3-15) had a peak 
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with reduced intensity compared to that observed for the IAA labeled fragment.  The 
ESAox modification with 6-IAF possibly reduced the ability of the digested fragments to 
become ionized in the MS.  The identified peptide clusters contained mostly interpeptide 
disulfide bonds fragment except for the cluster Tryp4 which contained a single 
intrapeptide segment bond.  Fragments containing intrapeptide bonds such as Tryp1 and 
6 can be difficult to get ionized due to its compact structure.   
Lys-C digested fragments showed similar digestion patterns compared to the 
trypsin digested fragments.  Lys-C produced identical IAA/6-IAF labeled ESAox 
fragments as that observed with trypsin, again confirming each chemical modification.  
Due to the reduced number of cleavage sites compared to the trypsin, the sizes of the 
digested fragments were generally larger.  Disulfide bonded peptide clusters Lysc2, 
Lysc4, and Lysc5 were detected using DHB and covered 54.0 % of the total IAA labeled 
ESAox sequence.  With Lys-C, more non-disulfide bonded fragments were detected 
which contributed to this higher sequence coverage.  Unlike the trypsin digested 
fragments, Lys-C created cluster Lysc7 which was composed of 4 large fragments linked 
by both intra and interpeptide disulfide bonds.  This largest cluster had a calculated 
molecular ion [M+H]+ = 9397.6 m/z which was not observed even using a different MS 
measurement methods, yet all the composed fragments were identified after reduction by 
DAN.    
Comparing the two proteolytic enzymes, Lys-C produced higher sequence 
coverage for both native (oxidized) and reduced ESA.  These results could be caused by 
the fact that the cleavage site for Lys-C is less in number, and therefore, less 
miscleavages.  Because there are a fewer number of cleavage sites for Lys-C, the size of 
the peptide clusters and non disulfide bonded fragments are generally larger.  Also, the 
ESA sequence contains several sites where lysine and arginine are located next to each 
other.  These types of sites caused miscleavages during tryptic digestion and also 
produced some short (mono-, di- and tri-) non-detectable peptides which affected the 
overall sequence coverage.  The observed difference in the cost of these two enzymes is 
also a consideration.  It costs considerably more to use Lys-C compared to trypsin.  
Therefore, as data suggests, one should start proteolytic digestion with trypsin.  Only 
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when higher sequence coverage is required, Lys-C can be used to enhance coverage.  
Using Lys-C as a primary proteolytic enzyme is not recommended due to its higher cost.       
For determining the cleaved peptides, the MS method used predominantly in these 
experiments was MALDI-TOF positive ion reflector mode.  This method only detects 
fragments which have a total positive ion charge.  Since extracted fragments were 
resuspended in 0.1 % TFA and DHB was also dissolved in 33 % acetonitrile/ 0.1 % TFA, 
sample applied to the MS measurement was dried in an acidic environment.  This 
condition protonates all the acidic amino acids such is glutamic acid and aspartic acid, 
thereby making peptides containing acidic amino acids measurable.  However, the 
intensity of the fragment peaks containing large number of acidic amino acids were 
generally lower due to a decrease in sensitivity.  Decreases in the sensitivity are generally 
caused by poor ionization and also higher mass molecular ions.    
The reason that we are not able to detect all of the disulfide bonded clusters can 
be explained by a difference in the energy absorption among the digested fragments.  
Some digested fragments were more easily ionized compared to the others.  Easily 
ionized fragments absorb more energy from the energy source leaving less energy to 
ionize the other fragments.  In other words, MS measurements are sequence dependant.  
It also signifies that the hydrophobic samples are easier to ionize into the gas-phase and 
be detected while highly hydrophilic samples are not.   
Miscleavage by the enzyme can be another reason for not recovering some 
fragments.  Miscleavage of the fragments generates new higher molecular weight 
fragments.  When the total molecular weight of the disulfide bonded cluster increases, the 
total ionization potential of the cluster can be decreased due to the presence of the 
additional amino acids.  In this case, poor ionization of the cluster could lead to not 
identifying certain clusters.  Overall, the sequence of ESA contains a large number of 
lysine and arginine.  Some of those cleavage sites could be located in the buried section 
of the native (oxidized) sample that was inaccessible to the protease.  As discussed in the 
introduction, the presence of disulfide bonds in the sample reduces the ionization 
potential of the segment.  This condition also contributes greatly to the lowering of the 
peak intensity.      
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 MS Analysis Using DAN 
The reducing capability of DAN matrix was demonstrated in the experiment using 
synthesized vasopressin as discussed above.  Proper preparation of the DAN solution is 
critical for obtaining the maximum reducing capability of DAN.  The trypsin digested 
peptide clusters of ESA were measured using DAN in order to investigate its oxidation 
states of the different fragments.  As one of the examples, Tryp8 (Figure 3-19) was 
shown to be made up of 3 tryptic fragments linked by 2 interpeptide disulfide bonds.  The 
molecular ion mass of the Tryp8 is [M+H]+ = 3658.8 m/z, which was previously detected 
using DHB.  This peak was barely present when the sample was mixed with DAN.  
Rather 3 peaks, fragments 483-489, 499-507, and 508-523 were observed having 
molecular ions of [M+H]+ = 841.4, 997.4, and 1823.9 m/z respectively.  As we observed 
in the vasopressin experiment, reduction by the DAN was not complete, therefore, some 
of the reduced peaks were seen with reduced intensities.  For example, the disulfide 
bonded cluster Tryp9 (Figure A-7) had [M+H]+ = 3581.5 not measured.  Tryp9 is 
composed of 3 fragments linked by 2 intrapeptide disulfide bonds.  Two out of three 
fragments, residues 527-544: [M+H]+ = 2066.9 m/z and 581-584: [M+H]+ = 438.1 m/z, 
were measured using DAN, but 588-597: [M+H]+ =1080.4 m/z was not.  Although the 
molecular ion of disulfide bonded cluster could not be measured, it was possible to 
identify several or all of the constituent fragments by measuring the sample using DAN.    
Similar results were obtained for the Lysc7 peptide cluster (Figure 3-24).  The 
cluster Lysc7 was composed of 4 fragments containing 4 disulfide bonds.  The total 
molecular ion was calculated as [M+H]+ = 9397.5 m/z and was not detected using DHB.  
However, peaks for all of the 4 fragments were detected after the sample was reduced 
with DAN.  Fragment 499-523: [M+H]+=2802.3 m/z was linked by both intra and 
interpeptide disulfide bonds.  In the Figure 3-24, the partially reduced intrapeptide 
disulfide bonded fragment 499-523 was observed as indicated in the pink trace me green 
trace), the main peak was observed 2 mass unit higher at [M+H]+ = 2802.068 m/z, 
indicating the reduction of an intrapeptide disulfide bond.   
Due to the energy dissipation caused by the presence of existing disulfide bonds, 
the measurement of oxidized peaks can be challenging.  However, with the help of 
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reducing ability of DAN, reduced fragments within an undetected disulfide linked peak 
become identified.  In other words, DAN helps to distinguish between intra and 
interpeptide disulfide bonds within a digested peptide.  If interpeptide disulfide bonds 
were formed, 2 additional peaks appear while the oxidized peak disappears or decreases.  
With the presence of an intrapeptide disulfide bond, the identified peak shifts 2 mass 
units higher.  DAN is a new type of matrix which can reduce existing disulfide bonds 
without pre-treating a sample with any reducing reagent.  This unique property of DAN 
contributes greatly to the field of protein structural analysis not only by shortening the 
analysis time, but also excluding the addition of any extra reducing chemicals or salts to 
the sample which could potentially interfere with the MS measurement.          
 
MS/MS Analysis 
The MS/MS measurements were carried out to identify the peak 1231 m/z (Figure 
3-16), obtained from the IAA labeled ESAred fragment.  There were two fragment 
possibilities for peak 1231 m/z; IAA labeled ESAred residues: CSSFQNFGER (223-232), 
or ACCDKPLLQK (300-309).  The precursor ion, [M+H]+ = 1231.517 m/z, was trapped 
and then fragmented with the application of higher laser energy which increases the 
potential energy of ions.  As a result, the partial sequence, SFQNF, was observed (Figure 
3-17).  This data confirmed the assignment of peak 1231 to fragment CSSFQNFGER, 
223-232.  MS/MS is one of the unique features of the MALDI-TOF/TOF MS instrument 
and becomes practical for the assignment of ambiguous peaks.  This technique is able to 
increase the usefulness of the instrument and often used for PMF (peptide mass 
fingerprint)-based protein identification21.  Combining MS and MS/MS data, protein 
identification/ characterization is becoming a requirement for publishing MS data.  
Additional protein data bases, a variety of search engines using different algorithms and 
de novo sequencing programs, are also contributing to the rapid process in protein 
identification.   
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Overall sequence coverage 
The sequence coverage obtained for each experiment is summarized in the 
Figures 4-1 and 4-2 for oxidized and reduced ESA samples, respectively.  Sequences 
generated by only trypsin are indicated in red, only Lys-C is blue, and by both enzymes is 
indicated in purple.  Sequences which were not identified using either enzymes are 
indicated in black.  Lys-C digestion (Red) generated more sequences that were not 
covered by the trypsin digestion (Blue) within the native ESAox sample, which again 
confirms the higher detection rate for this enzyme.  Residues 20-28, GVLRRDTHK, in 
the ESAred  were not detected by either enzymes (indicated in black).  While fragments up 
to Arg19 generated by trypsin digestion were identified, the theoretical fragment 
generated by the Lys-C hydrolysis (residues 3-28: [M+H]+ = 3085.673 m/z) was not 
detected due to its large ion mass.  The two sequences containing adjacent cysteine 
residues, 383-4 and 581-2 (underlined) were not discovered either in native (oxidized) or 
reduced ESA samples.  This could be indicating that those cys-cys residues are located in 
the tightly folded motif where either IAA or enzymes were not able to reach.  
Additionally, it is also possible that in the native ESAox sample, the presence of asparatic 
acids and glutamic acids near cys-cys residues are making negatively charged fragments 
which cannot be detected by the applied measuring method.  Even though the ESA 
sample was prepared in the acidic environment prior to the MS measurement, these 
particular fragments could not be fully protonated which, as result, caused poor ionization 
of the fragments.  The presence of an intrapeptide bond between Cys383-Cys392 could also 
be one of the reasons to cause the poor ionization due to the energy absorption by the 
cysteines.   
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Figure 4-1   ESAox sequence coverage  
Blue = by trypsin, Red = by Lys-C (red), Purple = by both enzymes  
  
 
Figure 4-2   ESAred sequence coverage  
Blue = by trypsin, Red = by Lys-C (red), Purple = by both enzymes  
 
 
Matrix Crystallization Comparison 
DHB (2,5-Dihydroxybenzoic acid), CCA (α-Cyano-4-hydroxycinnamic acid), and 
DAN (1,5-Diaminonaphthalene) are the three matrices used throughout this particular 
series of experiments.  Besides these three matrices, SA (Sinapic acid) and PNBA (2-
amino-5-nitrobenzoic acid) are often used for MALDI-TOF MS measurement.  It is 
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important to identify the appropriate matrix for each experiment in order to achieve the 
best ionization for the sample.  Obtaining good crystallization of the matrix on the target 
plate is also a critical item along with finding an optimal sample-to-matrix ratio.  Figures 
4-3 though 4-6 show pictures of crystallized matrices used in the experiment.   
DHB is often the matrix of choice for proteomics analyses such as the analysis of 
peptides after proteolytic digestion.  It forms needle-like crystals especially around the 
corner of the sample area on the target plate.  A minimum of 2 μL matrix/sample mixture 
was required in order to obtain the crystals shown in the Figure 4-3.  A number of 
conditions can interfere with crystals formation including: if samples contain high salts or 
contaminants, if more than 2 μL of the sample mixture is applied or if increasing the 
sample to matrix ratio is required to see crystals formation.  Crystallized DAN also forms 
meshed needles similar to the DHB but shorter and thinner (Figure 4-4).  Unlike DHB, 
matrix to sample ratio was kept 1:1 for DAN in this experiment.  Increasing the 
concentration of DAN caused problems in ionizing the sample for the MS measurement.  
Also using freshly prepared DAN was the most important point for the MS measurement.  
DAN starts oxidizing instantly after it is prepared as observed by a color change, from 
clear to dark grey.  On the other hand, CCA is very stable once it is prepared in a 
saturated solution.  It crystallizes to form small spheres (Figure 4-5) and mainly used for 
the analysis of smaller peptides such as synthesized peptides.  The baseline for CCA 
stays flat compared to the DHB which is useful when looking for less abundant sample.  
A combination of DHB and DAN matrices formed a different type of crystals (Figure 4-
6).  However, even though the crystal was formed, no detectable peaks were observed 
during the MS measurement.     
It is important to adjust the type, concentration, and the ratio of matrix in order to 
achieve better MS measurements.  Knowing the characteristics of the sample and 
adjusting the matrix referring to the each sample leads to improved MS measurements.   
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Figure 4-3   DHB crystal  
 
 
 
Figure 4-4   DAN crystal  
 
 
 
Figure 4-5   CCA crystal  
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Figure 4-6   DAN:DHB crystal    
 
PTM Investigation 
Glycosylation Detection  
As the glycoprotein stained gel image in the Figure 3-25 shows, no glycosylation 
in the native ESAox was detected.  Using the glycosylation staining kit was a very quick 
and easy way to probe for the glycoproteins.  The whole staining process took less than 2 
hours and there were no additional or unusual chemicals required.  However, this method 
can be unreliable considering the sensitivity of the staining kit.  Horseradish peroxidase 
(HP), 5 μg was used as a positive control (included in the kit), and has numerous 
glycosylation sites.  According to the instruction, as little as 0.16 μg of HP can be 
detected using this staining kit.  This suggests that in cases with samples containing only 
a few glycosylation sites or samples at lower concentration, glycosylation might not be 
detected.  Additionally, in order to assign the glycosylation sites, another method must be 
applied.  MS has often been used for mapping glycosylation sites after glycosylated 
sample was pre-treated with a glycosidase.  Mass differences observed between 
glycosylated and deglycosylated samples can be measured using MS to assign 
glycosylated sites to certain peptides.  For more precise mapping, one can combine this 
technique with liquid chromatography (LC/MS), to more easily detect the glycosylation 
sites.3   
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Phosphorylation Detection 
Phosphorylation of the ESAox sample was confirmed using the phosphoprotein gel 
staining kit.  As shown in the Figure 3-26, the ESA band was stained with the kit 
containing the phosphate reactive fluorescent dye.  The stained bands indicate 
phosphorylation.  However, the stained ESA band was much narrower compared to the 
one stained by Coomassie blue.  This could be indicating heterogeneous phosphorylation 
within the ESA sample.  If the protein was phosphorylated evenly throughout each mole 
of protein, the thickness of the bands should be equal as observed in the Coomassie blue 
stained sample, but with less intensity.  According to the information obtained from the 
Expasy Proteomics Server,31 there are only three potential phosphorylation sites, Ser82, 
Tyr108, and Tyr163 within the 607 residues of ESA which explain less intensity in the 
staining of ESA band relative to the control HP sample.  Phosphorylation of the protein is 
one of the most common protein modifications, particularly in the cellular signaling and 
regulation pathways.  It is achieved by the variety of kinases or other organic/inorganic 
phosphate donating groups, such as ATP, present within the cell.  Because it is one of the 
common PTMs, newer MS instruments can automatically detect the phosphorylation sites 
by simply recognizing the loss of 49 amu (atomic mass unit).  For example, the MALDI-
TOF MS instrument used in this experiment was often able to detect phosphorylation of 
the ESA sample during the sample analysis.  This was automatically informed by the 
analysis program after the measured data was transferred.  Because phosphate groups can 
be liberated from the amino acid residues by the addition of instrumental energy, the MS 
instrument was able to measure peaks of both phosphorylated and dephosphorylated 
fragments.   The data analysis program could detect the 49 amu difference between those 
two peaks which leads to the automatic assignment of the phosphorylation.     
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CHAPTER 5 - Conclusion 
Free cysteine and disulfide bonds present in the equine serum albumin (ESA) 
were characterized by using MALDI-TOF MS.  After chemical modifications of the 
sample and matrix adjustments, majority of the expected disulfide bonded clusters were 
assigned which matched with the disulfide mapping reported from the x-ray 
crystallography experiment.28  Total sequence coverage of native and reduced ESA 
reached to 73.6 % and 92.6 %, respectively when combining both the trypsin and Lys-C 
data.  Acquired data from this experiment using MALDI-TOF MS confirmed the 
disulfide bonds sites reported by x-ray crystallography, but in a much more efficient way.  
Modifying the free cysteine in the ESAox was an important step before proceeding to the 
further analysis.  Labeling the free cysteine with florescent dye (6-IAF) was effective 
because not only was the reaction irreversible, but also because it was visible to unaided 
eyes.  Due to a large number of disulfide bonds present in the native ESAox, some of the 
digested fragments were still cross-linked after denaturation.  However, using DAN, a 
new type of reducing matrix, those disulfide bonds were reduced instantly on the sample 
plate with just the addition of MALDI laser energy.  Additionally, since the sample was 
separated, labeled and digested within the gel, more MS peaks with higher intensities and 
sensitivities were obtained.  These facts make it possible to achieve higher sequence 
coverage of the protein which is important for the characterization of the protein 
sequences along with the assignment of all the PTM sites.  Figure 5-1 is a summary of an 
optimized protocol based on our studies.  For the disulfide bond mapping using MALDI-
TOF MS, it is recommended to follow such protocol for obtaining better results. 
 MALDI-TOF MS is one of the common protein analysis tools that can provide 
extensive information in a short time frame while keeping the sample in its native state.  
A protein containing disulfide bonds is poorly ionized with MALDI which leading to a 
decrease in the sensitivity of the instrument.  However, by using a new type of matrix and 
performing a sample digestion with suitable proteolytic enzymes, it is possible to 
overcome such problems.  Nowadays, the investigation of PTMs has been a big focus in 
the field of proteomics.  Even though different separation techniques or ionization 
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methods, capillary electrophoresis and liquid or gas chromatography, are combined to the 
MS, idealization and optimization of such will be the challenge that we all must 
overcome in the future. 
 
Chemical Modification (6-IAF or IAA treatment) 
of the free cysteine in native protein
Sample purification & isolation using SDS-PAGE 
(10-20% Tricine gel)
Reduction and carboxymethylation (Optional) 
Proteolytic digestion (1°=Trypsin, 2°=Lys-C)
Sample extraction from SDS gel (0.1% TFA in 50% ACN /H2O)
MALDI-TOF MS measurement
DHB for reduced/carboxymethylated sample
DHB & DAN for disulfide bonded sample
Peak confirmation by MS/MS measurement
Peak identification by Flex analysis
Peak assignment by Mascot (Search engine)
Optimized protocol for disulfide bond mapping using MALDI-TOF MS
 
Figure 5-1   Summary of optimized protocol for disulfide bond mapping  
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                    List of Abbreviations 
ES, equine serum 
ESA, equine serum albumin 
ESAox, native (oxidized) equine serum albumin 
ESAred, reduced equine serum albumin 
HSA, human serum albumin 
BSA, bovine serum albumin 
6-IAF, 6-Iodoacetamido fluorescein 
IAA, Iodoacetamide 
HP, horseradish peroxidase 
TI, soybean trypsin inhibitor 
GDH, glutamic dehydrogenase 
DHB, 2,5-Dihydroxybenzoic acid 
DAN, 1,5-Diaminonaphthalene 
CCA, α-Cyano-4-hydroxycinnamic acid 
amu, atomic mass unit 
a.u, arbitrary unit 
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 Appendix A - Trypsin digested fragments 
91
2.
87
8
84
1.
94
4
15
94
.9
65
98
6.
94
1
14
54
.9
23
11
92
.8
72
14
14
.8
37
18
73
.9
18
11
48
.8
84
0
1
2
3
4
5
6
4x10
In
te
ns
. [
a.
u.
]
600 800 1000 1200 1400 1600 1800 2000
m /z
77                            86
KCAADESAENCDK 
Tryp1
1381.61383.676-86
(ox)(red)Fragment (mc1)
IAF labeled ESA /DHB
IAF labeled ESA /DAN
13
83
.7
81
0
200
400
600
800
In
te
ns
. [
a.
u.
]
1378 1380 1382 1384 1386
m/z
1383.781
1381.664
 
Figure A-1   MS spectra of Tryp1  (1 miscleavage) 
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Figure A-2   MS spectra of Tryp2 
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Figure A-3   MS spectra of Tryp4 
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Figure A-4   MS spectra of Tryp5 
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Figure A-5   MS spectra of Tryp6 
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Figure A-6   MS spectra of Tryp7 
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Figure A-7   MS spectra of Tryp9 
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Figure B-1   MS spectra of IAA labeled ESAox 
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Figure B-2   MS spectra of Lysc2 
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Figure B-3   MS spectra of Lysc4 
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Figure B-4   MS spectra of Lysc5 
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Figure B-5   MS spectra of Lysc8 
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